KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Short term Debt: 2010-2025

Historic Short term Debt for Opko Health (OPK) over the last 14 years, with Sep 2025 value amounting to $12.8 million.

  • Opko Health's Short term Debt fell 3.31% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year decrease of 3.31%. This contributed to the annual value of $14.8 million for FY2024, which is 45.59% down from last year.
  • Opko Health's Short term Debt amounted to $12.8 million in Q3 2025, which was down 8.83% from $14.0 million recorded in Q2 2025.
  • Opko Health's 5-year Short term Debt high stood at $33.5 million for Q4 2022, and its period low was $12.1 million during Q1 2025.
  • Its 3-year average for Short term Debt is $20.2 million, with a median of $22.1 million in 2024.
  • As far as peak fluctuations go, Opko Health's Short term Debt skyrocketed by 128.24% in 2022, and later plummeted by 56.10% in 2024.
  • Opko Health's Short term Debt (Quarterly) stood at $14.7 million in 2021, then skyrocketed by 128.24% to $33.5 million in 2022, then decreased by 18.63% to $27.3 million in 2023, then crashed by 45.59% to $14.8 million in 2024, then declined by 3.31% to $12.8 million in 2025.
  • Its last three reported values are $12.8 million in Q3 2025, $14.0 million for Q2 2025, and $12.1 million during Q1 2025.